Katharine Peterson insider trades
Open-market stock purchases and sales by Katharine Peterson, Chief Accounting Officer at Acrivon Therapeutics, Inc, from SEC Form 4 filings since May 14, 2024.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 18, 2026 | ACRV Acrivon Therapeutics, Inc | Bought (not open market) | — |
| May 14, 2026 | ACRV Acrivon Therapeutics, Inc | Sold (not open market) | $190 |
| Mar 1, 2026 | ACRV Acrivon Therapeutics, Inc | Bought (not open market) | — |
| Feb 14, 2026 | ACRV Acrivon Therapeutics, Inc | Sold (not open market) | $189 |
| Nov 14, 2025 | ACRV Acrivon Therapeutics, Inc | Sold (not open market) | $222 |
Companies traded
- ACRV Acrivon Therapeutics, Inc: other filings, last May 18, 2026